Compare TWLO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWLO | GEHC |
|---|---|---|
| Founded | 2008 | 1892 |
| Country | United States | United States |
| Employees | 5587 | N/A |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8B | 29.9B |
| IPO Year | N/A | 2022 |
| Metric | TWLO | GEHC |
|---|---|---|
| Price | $209.31 | $65.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 13 |
| Target Price | ★ $151.54 | $88.38 |
| AVG Volume (30 Days) | 2.2M | ★ 4.3M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $14.44 | $7.12 |
| Revenue Next Year | $8.21 | $4.45 |
| P/E Ratio | $526.76 | ★ $77.18 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $91.84 | $58.75 |
| 52 Week High | $238.48 | $89.77 |
| Indicator | TWLO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.50 | 55.23 |
| Support Level | $179.78 | $60.08 |
| Resistance Level | $238.48 | $78.85 |
| Average True Range (ATR) | 9.18 | 1.78 |
| MACD | 0.59 | 0.28 |
| Stochastic Oscillator | 91.91 | 86.48 |
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).